{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:10:47Z","timestamp":1789582247086,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005188","name":"AAIR Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022419","name":"NIHR Southampton Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["35,000"],"award-info":[{"award-number":["35,000"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jaip.2023.05.028","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:37:50Z","timestamp":1685068670000},"page":"2812-2821.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Comprehensive Characterization of Difficult-to-Treat Asthma Reveals Near Absence of T2-Low Status"],"prefix":"10.1016","volume":"11","author":[{"given":"Hitasha","family":"Rupani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Aref","family":"Kyyaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Azim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Abadalkareen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paddy","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratko","family":"Djukanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandurangan","family":"Vijayanand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Seumois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Hasan","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Michael","family":"Haitchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh J.","family":"Kurukulaaratchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.05.028_bib1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaip.2019.11.006","article-title":"T2-\u201clow\u201d asthma: overview and management strategies","volume":"8","author":"Fitzpatrick","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.028_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00528-2020","article-title":"Treatment options in type-2 low asthma","volume":"57","author":"Hinks","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.028_bib3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/cea.13882","article-title":"Real-world omalizumab and mepolizumab treated difficult asthma phenotypes and their clinical outcomes","volume":"51","author":"Fong","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.028_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.028_bib5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMra1608969","article-title":"Severe and difficult-to-treat asthma in adults","volume":"377","author":"Israel","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.028_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaci.2013.07.036","article-title":"Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma","volume":"133","author":"Peters","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.028_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/thoraxjnl-2020-215168","article-title":"Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era","volume":"76","author":"Jackson","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.05.028_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12890-019-0862-2","article-title":"Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic","volume":"19","author":"Azim","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2023.05.028_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/cea.13841","article-title":"Clinical evaluation of type 2 disease status in a real-world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts","volume":"51","author":"Azim","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.028_bib10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.chest.2021.04.013","article-title":"Eosinophilic and non-eosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort","volume":"160","author":"Heaney","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2023.05.028_bib11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/cea.14109","article-title":"Validation and further insight into the International Severe Asthma Registry (ISAR) eosinophil gradient algorithm in the Wessex AsThma CoHort of difficult asthma (WATCH) using historical blood eosinophil counts and induced sputum","volume":"52","author":"Barber","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.028_bib26","unstructured":"GINA. Difficult-to-Treat & Severe Asthma in adolescent and adult patients.\u00a0Diagnosis and Management. v 3.0. 2021. Accessed April 19, 2023. https:\/\/ginasthma.org\/wp-content\/uploads\/2023\/04\/GINA-Main-Report-2021-V2-WMSA.pdf"},{"key":"10.1016\/j.jaip.2023.05.028_bib13","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.jaip.2020.05.053","article-title":"New perspectives on difficult asthma; sex and age of asthma-onset based phenotypes","volume":"8","author":"Azim","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"suppl 63","key":"10.1016\/j.jaip.2023.05.028_bib14","first-page":"PA2543","article-title":"Variability in blood eosinophils: findings from the WATCH cohort of difficult asthma","volume":"54","author":"Azim","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.028_bib15","author":"Oliveros"},{"key":"10.1016\/j.jaip.2023.05.028_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.05.028_bib18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jaip.2020.09.051","article-title":"The prevalence of subtypes of type 2 inflammation in an unselected population of patients with severe asthma","volume":"9","author":"Frossing","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.028_bib19","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1164\/rccm.202009-3713OC","article-title":"Mixed sputum granulocyte longitudinal impact on lung function in the Severe Asthma Research Program","volume":"203","author":"Hastie","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.05.028_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1164\/rccm.201807-1291OC","article-title":"A\u00a0transcriptomic method to determine airway immune dysfunction in T2-high and T2-low asthma","volume":"199","author":"Peters","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.05.028_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.anai.2022.04.020","article-title":"T2-low: what do we know? Past, present, and future of biologic therapies in noneosinophilic asthma","volume":"129","author":"Niessen","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.028_bib22","doi-asserted-by":"crossref","first-page":"00309","DOI":"10.1183\/23120541.00309-2020","article-title":"Identification and treatment of T2-low asthma in the era of biologics","volume":"7","author":"Kyriakopoulos","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2023.05.028_bib23","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/all.14732","article-title":"Peripheral airways type 2 inflammation, neutrophilia and microbial dysbiosis in severe asthma","volume":"76","author":"Azim","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.028_bib24","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1111\/all.15375","article-title":"Nontypeable Haemophilus influenzae infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma","volume":"77","author":"Ackland","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.028_bib25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaip.2022.11.025","article-title":"Association between blood eosinophils and neutrophils with clinical features in adult-onset asthma","volume":"11","author":"Flinkman","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:32Z","timestamp":1761975512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823005664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213219823005664"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.028","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Characterization of Difficult-to-Treat Asthma Reveals Near Absence of T2-Low Status","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}